Company intelligence / Profile preview

Procaps Group

Barranquilla, Atlántico, Colombia

Ownership: Private
Employees: ~5000
Development stage: Other

Overview

Procaps/“Crynssen Pharma Group” is a leading Latin American provider of proprietary Rx and OTC drugs, with more than 500 formulations commercialized and a robust pipeline of >50 new products per year, specializing in differentiated oral delivery technology and softgel production

Therapeutic areas: CardiovascularOtherEndocrinology
Modalities: Small moleculeBiologicSoft gelatin capsuleNutritional supplement
Industry: Biotech

Partnerships

GlaxoPfizerAbbott

Beyond the preview

Go deeper on Procaps Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Procaps Group.

Explore the full profile